Drug Discovery Technology World Asia 2010
Our media partners
Capitalise on this ideal platform to market your publication and form strategic relationships through networking at Drug Discovery Technology World Asia 2010!
- Brand your publication with an event that the industry believes in
- Fully capitalise on our integrated marketing campaign
- Increased customer contact and business opportunities
- Wider exposure to Asian and international organisations
- An unique opportunity to give clients “hands on” experience with your products / services
- Garner exclusive interview with the region’s movers and shakers
- Avail yourself of invaluable editorial & feature content at the conference
» Contact Esther Chan at +65 6322 2742 for more information on media partnerships and endorsement opportunities.
Meet our confirmed media partners...
International Marketing Partner:
|
|
|
Bio-Outsourcing Asia© provides a comprehensive view of outsourcing issues facing the biopharmaceutical and biomedical industries as partnerships are formed with India, China, Taiwan, Malaysia, and other emerging Asian markets. http://www.canbiotech.com/CBBOA.asp
|
|
|
|
BioPharmaLife-India, the International publication is brought out as a bi-monthly to route the BIOTECH & PHARMA OUTSOURCING activities to India from US and Europe BioPharmaLife contains up-to-date information on current outsourcing trends in areas of Drug Discovery, Development, Decease Research, Contract Research and manufacturing, Clinical Research, Clinical Trials, BioInformatics and related technology updates covering India, USA, Europe and Asia pacific regions, catering to both the buyers and service providers of Biotech and Pharma outsourcing. It includes in-depth articles, features, interviews, write-ups and extensive coverage of International Biotech & Pharma outsourcing conferences / exhibitions held worldwide.
|
|
|
|
CRO Asia © is a premium online media platform targeting pharmaceutical outsourcing industry namely contract research and manufacturing organizations (CROs and CMOs) based in Asia-Pacific regions.
CRO Asia's unique and innovative partnering approach is to present a wide variety of contract service providers in Asia-Pacific to a highly specialized audience of scientists, professionals and decision makers in pharmaceutical industry. Our objective is to forge potential collaborations and strategic partnerships between those two parties by using our unique marketing tools and quality communication services.
For more information, please visit us at http://www.croasia.net
|
|
|
|
General Biologic is a business intelligence and professional services firm focused on China’s biotechnology, pharmaceutical, and healthcare industries. We provide our clients with information, analysis, and advice enabling confident and informed decision making. Our offerings include information products such as our monthly publication- the China Pharmaceutical & Biotechnology Monthly, our recently launched SOURCE China pharmaceutical data service, and in-depth sector-specific reports covering areas including vaccines, molecular diagnostics, retail pharmacies, and others. We also provide our clients, which range from mid-size biotechnology companies to MNC pharma, with bespoke management consulting and advisory services focusing exclusively on the healthcare and pharmaceutical sectors in China. The GB team is made up of Western and Chinese professionals with backgrounds in medicine, life-science, and finance who have deep familiarity with the China healthcare and pharmaceutical business landscape.
|
|
|
|
Now in its 26th year, GEN retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D. Genetic Engineering & Biotechnology News (GEN), the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide. GEN's unique news editorial mandate is the entirety of the bioproduct life cycle, from early-stage R&D, to applied research and bioprocess, through to commercialization, including marketing and regulatory. GEN is the only publication with this mandate, covering the entirety of commercial bioscience: biopharmaceuticals, bio-agriculture, chemicals and enzymes, and environmental markets, and emerging biosciences including biodefense, bioenergy, and nanobiotechnology. GEN has from the beginning fused industry, academia and government, to foster industry collaborations and agreements.
|
|
|
|
goBalto is the quick and easy way to find, evaluate, and manage drug-development partners from around the world. You already know that turning to your colleagues is the best way to find contract research and manufacturing organizations, consultants, investigator sites and other service providers. We make that process simple by collecting and organizing your list of service providers in one place. www.gobalto.com
|
|
|
|
MarketsandMarkets is a full service and consulting firm that produces strategically analyzed full length reports track more than 10 industries. By FYE 2010 M&M plans to launch industry-wise and country wise market tracker for all the verticals tracked. This intelligence database comprising of about 60000 reports a year will form one of the world's largest intelligence resources worldwide. MarketsandMarkets has effectively used technology to automate management of large and complex data for forecasts. MarketsandMarkets aspires to help its client to achieve sustainable growth by providing incisive business insights into their respective business partners. Our 200 global strategic accounts with topline revenues in excess of USD 1 Billion annually. Delivered syndicated research studies to top publishers globally on a subcontracting model. The major industries that we cover in our market intelligence deliverables are Pharma & Biotech, Telecom & IT, Healthcare & Life sciences, Chemical & Advanced Material, Electronics & Semiconductor, Foods & Beverages,
|
|
|
|
Outsourcing2india, the International publication brought out every month to promote the futuristic and ongoing business of OUTSOURCING to India from US, Europe and Asia Pacific.
Outsourcing2india contains up-to-date information on current outsourcing trends in USA, Europe and Asia both for the buyers and service providers of outsourcing. It includes in-depth articles, features, interviews and write-ups on IT outsourcing, Mfg outsourcing, Technology outsourcing, Software Development, BPO, ITES, Call / Contact centers, Off shoring / Near shoring, Business continuity planning, Disaster recovery and extensive coverage of International outsourcing conferences / seminars held worldwide - all sourced from International outsourcing analysts, domain experts, professional consultants and news agencies around the world.
|
|
|
|
PharmaAsia keeps tabs on the industry, and provides you with the information you need to take the next step forward. The publication provides timely and useful insights into cutting edge techniques and practices for improving the pace of pharmaceutical research and development in the region. PharmaAsia features articles on research and technology relevant to the industry and offers news and market trends, product listings, updates on regional events and profiles of relevant companies and service providers. For more information, contact Alvin Lim at +65 6780 4521 or alvin.lim@rbi-asia.com
|
|
|
|
PharmaAsia News delivers highly specialized industry insight on the rapidly expanding Asian marketplace, including analysis of regulatory and commercial developments from bureaus across Asia, exclusive interviews, special guest columns, continuously updated newsfeeds and editor's picks from Asia.
http://pharmasianews.elsevierbi.com
|
|
|
|
Pharma Connections Worldwide® offers business networking, consulting sales and advertising services focused in the global pharmaceutical, biotechnology and life sciences community. With current members from over one hundred countries, our goal is to become a premiere conduit for business development professionals in a global marketplace.
Register for free at Pharma Connections Worldwide® .
|
|
|
|
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical/biopharmaceutical industry and market. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most multinational pharmaceutical companies, leading CROs, investment banks, consulting firms and industry associations active in China.
The Pharma China product portfolio is composed of four core products:
Pharma China Journal Edition - Monthly business journal in PDF and Print providing latest news, inside stories, in-depth analysis of issues and trends, and expert insights on China’s pharmaceutical industry and market.
Pharma China Web Edition - Online business information and resource platform providing continuously-updated news and in-depth commentaries on China's healthcare business arena. A number of high-value databases are being added to the site.
China Pharmaceutical Guide – Annually updated and written by veteran industry executives, it is the most comprehensive and authoritative guide to the Chinese pharmaceutical industry and market available in English.
SNAPI (Database-driven Sino-API Intelligence) – The only reliable English database of Chinese API products and producers available in CD and online access versions. Continuously researched and updated, the database provides indispensable information on nearly 1,000 major Chinese API producers and thousands of API drug products. www.pharmachinaonline.com
|
|
|
|
|
|
Session sponsor:
Exhibitors:
|
asia research institution poster presentation
* For first 20 confirmed poster presentations
|
|
|
